Related Experiment Video
Updated: Jan 17, 2026

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Mesalazine-induced neutropenia: a rare idiosyncratic reaction
Deloshaan Subhaharan1,2, Waled Mohsen3
1Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Queensland, Australia delo.subhaharan@hotmail.com.
None:
Mesalazine is a 5-aminosalicylate commonly used in the treatment of ulcerative colitis. It has been very rarely associated with neutropenia. We report a woman in her 30s who developed neutropenia 2 years after starting mesalazine. She had not been started on any other medications and extensive investigation for alternative causes of neutropenia were unremarkable. Mesalazine was discontinued and her neutrophil count normalised within 2 weeks.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Allergic Drug Reactions
Drugs for Treatment of Constipation-Predominant IBS
Allergic Reactions
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...